BACKGROUND: Development of Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) requires adequate preclinical models. METHODS: The model should be easy to use, reproducible and cost-effective. It should have a volume similar to the human abdominal cavity, and an oval shape. The inner surface should be lined with serosa. The model should allow pharmacological and biological analysis, including histology. No living animals should be used. RESULTS: The fresh urinary bladder is explanted from an adult bovine in the slaughterhouse. A 4-cm incision is performed into the bladder neck. The bladder can be inverted through the incision, which allows exposition of the serosa on its inner side. A balloon trocar is inserted through the incision and a ligature placed, ensuring full tightness. The therapeutic capnoperitoneum is installed. The bovine bladder has a volume somewhat smaller (2-3 L) than the human abdominal cavity (3-5 L). Costs are minimal. There is no significant bacteriological contamination. Manipulation is simple. CONCLUSIONS: The (inverted) bovine urinary bladder is an innovative and versatile ex vivo model for optimizing drug delivery with therapeutic aerosols both onto the mucosa or the serosa. This model can be used for pharmaceutical Quality-by-Design approaches and will replace a large number of experiments in the animal.
BACKGROUND: Development of Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) requires adequate preclinical models. METHODS: The model should be easy to use, reproducible and cost-effective. It should have a volume similar to the human abdominal cavity, and an oval shape. The inner surface should be lined with serosa. The model should allow pharmacological and biological analysis, including histology. No living animals should be used. RESULTS: The fresh urinary bladder is explanted from an adult bovine in the slaughterhouse. A 4-cm incision is performed into the bladder neck. The bladder can be inverted through the incision, which allows exposition of the serosa on its inner side. A balloon trocar is inserted through the incision and a ligature placed, ensuring full tightness. The therapeutic capnoperitoneum is installed. The bovine bladder has a volume somewhat smaller (2-3 L) than the human abdominal cavity (3-5 L). Costs are minimal. There is no significant bacteriological contamination. Manipulation is simple. CONCLUSIONS: The (inverted) bovine urinary bladder is an innovative and versatile ex vivo model for optimizing drug delivery with therapeutic aerosols both onto the mucosa or the serosa. This model can be used for pharmaceutical Quality-by-Design approaches and will replace a large number of experiments in the animal.
Authors: Veria Khosrawipour; Tanja Khosrawipour; Alexander Jens Peter Kern; Aras Osma; Burak Kabakci; David Diaz-Carballo; Eckart Förster; Jürgen Zieren; Khashayar Fakhrian Journal: J Cancer Res Clin Oncol Date: 2016-09-02 Impact factor: 4.553
Authors: Wiebke Solass; Aurélie Herbette; Tina Schwarz; Alexander Hetzel; Jian-Sheng Sun; Marie Dutreix; Marc A Reymond Journal: Surg Endosc Date: 2011-11-01 Impact factor: 4.584
Authors: Wiebke Solass; Reinhold Kerb; Thomas Mürdter; Urs Giger-Pabst; Dirk Strumberg; Clemens Tempfer; Jürgen Zieren; Matthias Schwab; Marc André Reymond Journal: Ann Surg Oncol Date: 2013-09-05 Impact factor: 5.344
Authors: Tinatin Kakchekeeva; Cedric Demtröder; Nirmitha I Herath; Dominic Griffiths; Jared Torkington; Wiebke Solaß; Marie Dutreix; Marc A Reymond Journal: Ann Surg Oncol Date: 2016-02-02 Impact factor: 5.344
Authors: Mustafa Raoof; Gautam Malhotra; Adrian Kohut; Michael O'Leary; Paul Frankel; Thuy Tran; Marwan Fakih; Joseph Chao; Dean Lim; Yanghee Woo; Isaac B Paz; Michael Lew; Mihaela C Cristea; Lorna Rodriguez-Rodriguez; Yuman Fong; Andrew Blakely; Richard Whelan; Marc A Reymond; Amit Merchea; Thanh H Dellinger Journal: Ann Surg Oncol Date: 2021-08-13 Impact factor: 5.344
Authors: Leen Van de Sande; Wouter Willaert; Sarah Cosyns; Kaat De Clercq; Molood Shariati; Katrien Remaut; Wim Ceelen Journal: BMC Cancer Date: 2019-05-07 Impact factor: 4.430
Authors: Daniel Göhler; Ralf Gritzki; Antje Geldner; Franz Lohse; Stephan Große; Julien Sobilo; Clemens Felsmann; Jonathan R Buggisch; Alain Le Pape; Andreas Rudolph; Michael Stintz; Urs Giger-Pabst Journal: Sci Rep Date: 2021-11-08 Impact factor: 4.379
Authors: Phil Höltzcke; Iaroslav Sautkin; Samuel Clere; Arianna Castagna; Alfred Königsrainer; Peter P Pott; Marc A Reymond Journal: Surg Endosc Date: 2022-08-29 Impact factor: 3.453
Authors: C Bachmann; I Sautkin; G Nadiradze; R Archid; F J Weinreich; A Königsrainer; M A Reymond Journal: Surg Endosc Date: 2021-06-10 Impact factor: 4.584